| Year | Title | Author(s) |
| 2024 |
The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury
Biomedicine & Pharmacotherapy |
Katerelos, M Gleich, K Harley, G Loh, K Oakhill, JS Kemp, BE de Souza, DP Narayana, VK Coughlan, MT Laskowski, A Ling, NXY Murray-Segal, L Brink, R Lee, M Power, DA Mount, PF |
| 2022 |
Disrupting AMPK-Glycogen Binding in Mice Increases Carbohydrate Utilization and Reduces Exercise Capacity
Frontiers In Physiology |
Janzen, NR Whitfield, J Murray-Segal, L Kemp, BE Hawley, JA Hoffman, NJ |
| 2022 |
Blocking AMPK?1 myristoylation enhances AMPK activity and protects mice from high-fat diet-induced obesity and hepatic steatosis
Cell Reports |
Neopane, K Kozlov, N Negoita, F Murray-Segal, L Brink, R Hoque, A Ovens, AJ Tjin, G McAloon, LM Yu, DY Ling, NXY Sanders, MJ Oakhill, JS Scott, JW Steinberg, GR Loh, K Kemp, BE Sakamoto, K Galic, S |
| 2022 |
An AMPKa2-specific phospho-switch controls lysosomal targeting for activation
Cell Reports |
Morrison, KR Smiles, WJ Ling, NXY Hoque, A Shea, G Ngoei, KRW Yu, DY Murray-Segal, L Scott, JW Galic, S Kemp, BE Petersen, J Oakhill, JS |
| 2021 |
Mice with Whole-Body Disruption of AMPK-Glycogen Binding Have Increased Adiposity, Reduced Fat Oxidation and Altered Tissue Glycogen Dynamics
International Journal Of Molecular Sciences |
Janzen, NR Whitfield, J Murray-Segal, L Kemp, BE Hawley, JA Hoffman, NJ |
| 2020 |
Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism
Molecular Metabolism |
Hoffman, NJ Whitfield, J Janzen, NR Belhaj, MR Galic, S Murray-Segal, L Smiles, WJ Ling, NXY Dite, TA Scott, JW Oakhill, JS Brink, R Kemp, BE Hawley, JA |
| 2020 |
The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPK alpha 2
Febs Journal |
Lee, JO Byun, WS Kang, MJ Han, JA Moon, J Shin, MJ Lee, HJ Chung, JH Lee, JS Son, CG Song, KH Kim, TW Lee, ES Kim, HM Chung, CH Ngoei, KRW Ling, NXY Oakhill, JS Galic, S Murray-Segal, L Kemp, BE Kim, KM Lim, S Kim, HS |
| 2019 |
Inhibition of Adenosine Monophosphate-Activated Protein Kinase-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Signaling Leads to Hypercholesterolemia and Promotes Hepatic Steatosis and Insulin Resistance
Hepatol. Commun. |
Loh, K Tam, S Murray-Segal, L Huynh, K Meikle, PJ Scott, JW van Denderen, B Chen, ZP Steel, R LeBlond, ND Burkovsky, LA O’Dwyer, C Nunes, JRC Steinberg, GR Fullerton, MD Galic, S Kemp, BE |
| 2019 |
ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways
Faseb Journal |
Lee, HJ Moon, J Chung, I Chung, JH Park, C Lee, JO Han, JA Kang, MJ Yoo, EH Kwak, SY Jo, G Park, W Park, J Kim, KM Lim, S Ngoei, KRW Ling, NXY Oakhill, JS Galic, S Murray-Segal, L Kemp, BE Mantzoros, CS Krauss, RM Shin, MJ Kim, HS |
| 2018 |
AMPK signaling to acetyl-CoA carboxylase is required for fasting- and cold-induced appetite but not thermogenesis
Elife |
Galic, S Loh, K Murray-Segal, L Steinberg, GR Andrews, ZB Kemp, BE |
| 2018 |
CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages
J. Autoimmun. |
Samudra, AN Dwyer, KM Selan, C Freddi, S Murray-Segal, L Nikpour, M Hickey, MJ Peter, K Robson, SC Sashindranath, M Cowan, PJ Nandurkar, HH |
| 2016 |
Human Endothelial Protein C Receptor Overexpression Protects Intraportal Islet Grafts in Mice
Transplant. Proc. |
Gock, H Lee, KFE Murray-Segal, L Mysore, TB d’Apice, AJF Salvaris, EJ Cowan, PJ |
| 2013 |
The Protective Effects of CD39 Overexpression in Multiple Low-Dose Streptozotocin-Induced Diabetes in Mice
Diabetes |
Chia, JSJ McRae, JL Thomas, HE Fynch, S Elkerbout, L Hill, P Murray-Segal, L Robson, SC Chen, JF d’Apice, AJF Cowan, PJ Dwyer, KM |